500 related articles for article (PubMed ID: 31907988)
1. The xenobiotic sensing pregnane X receptor regulates tissue damage and inflammation triggered by C difficile toxins.
Erickson SL; Alston L; Nieves K; Chang TKH; Mani S; Flannigan KL; Hirota SA
FASEB J; 2020 Feb; 34(2):2198-2212. PubMed ID: 31907988
[TBL] [Abstract][Full Text] [Related]
2. Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure.
Hirota SA; Iablokov V; Tulk SE; Schenck LP; Becker H; Nguyen J; Al Bashir S; Dingle TC; Laing A; Liu J; Li Y; Bolstad J; Mulvey GL; Armstrong GD; MacNaughton WK; Muruve DA; MacDonald JA; Beck PL
Infect Immun; 2012 Dec; 80(12):4474-84. PubMed ID: 23045481
[TBL] [Abstract][Full Text] [Related]
3. The P2Y6 receptor mediates Clostridium difficile toxin-induced CXCL8/IL-8 production and intestinal epithelial barrier dysfunction.
Hansen A; Alston L; Tulk SE; Schenck LP; Grassie ME; Alhassan BF; Veermalla AT; Al-Bashir S; Gendron FP; Altier C; MacDonald JA; Beck PL; Hirota SA
PLoS One; 2013; 8(11):e81491. PubMed ID: 24278446
[TBL] [Abstract][Full Text] [Related]
4. The role of purified Clostridium difficile glucosylating toxins in disease pathogenesis utilizing a murine cecum injection model.
Zhang Y; Yang Z; Gao S; Hamza T; Yfantis HG; Lipsky M; Feng H
Anaerobe; 2017 Dec; 48():249-256. PubMed ID: 29031928
[TBL] [Abstract][Full Text] [Related]
5. Clostridioides difficile Toxin A Remodels Membranes and Mediates DNA Entry Into Cells to Activate Toll-Like Receptor 9 Signaling.
Chen X; Yang X; de Anda J; Huang J; Li D; Xu H; Shields KS; Džunková M; Hansen J; Patel IJ; Yee EU; Golenbock DT; Grant MA; Wong GCL; Kelly CP
Gastroenterology; 2020 Dec; 159(6):2181-2192.e1. PubMed ID: 32841647
[TBL] [Abstract][Full Text] [Related]
6. Human intestinal enteroids as a model of
Engevik MA; Danhof HA; Chang-Graham AL; Spinler JK; Engevik KA; Herrmann B; Endres BT; Garey KW; Hyser JM; Britton RA; Versalovic J
Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G870-G888. PubMed ID: 32223302
[No Abstract] [Full Text] [Related]
7. Murine Intrarectal Instillation of Purified Recombinant
Markham NO; Bloch SC; Shupe JA; Laubacher EN; Thomas AK; Kroh HK; Childress KO; Peritore-Galve FC; Washington MK; Coffey RJ; Lacy DB
Infect Immun; 2021 Mar; 89(4):. PubMed ID: 33468584
[No Abstract] [Full Text] [Related]
8.
McKee HK; Kajiwara C; Yamaguchi T; Ishii Y; Shimizu N; Ohara A; Tateda K
J Med Microbiol; 2021 Apr; 70(4):. PubMed ID: 33830910
[No Abstract] [Full Text] [Related]
9. Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.
Carter GP; Chakravorty A; Pham Nguyen TA; Mileto S; Schreiber F; Li L; Howarth P; Clare S; Cunningham B; Sambol SP; Cheknis A; Figueroa I; Johnson S; Gerding D; Rood JI; Dougan G; Lawley TD; Lyras D
mBio; 2015 Jun; 6(3):e00551. PubMed ID: 26037121
[TBL] [Abstract][Full Text] [Related]
10. Contribution of adenosine A(2B) receptors in Clostridium difficile intoxication and infection.
Warren CA; Li Y; Calabrese GM; Freire RS; Zaja-Milatovic S; van Opstal E; Figler RA; Linden J; Guerrant RL
Infect Immun; 2012 Dec; 80(12):4463-73. PubMed ID: 23045479
[TBL] [Abstract][Full Text] [Related]
11. A leaky human colon model reveals uncoupled apical/basal cytotoxicity in early
Ok MT; Liu J; Bliton RJ; Hinesley CM; San Pedro EET; Breau KA; Gomez-Martinez I; Burclaff J; Magness ST
Am J Physiol Gastrointest Liver Physiol; 2023 Apr; 324(4):G262-G280. PubMed ID: 36749911
[No Abstract] [Full Text] [Related]
12. The Importance of Therapeutically Targeting the Binary Toxin from
Abeyawardhane DL; Godoy-Ruiz R; Adipietro KA; Varney KM; Rustandi RR; Pozharski E; Weber DJ
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805767
[TBL] [Abstract][Full Text] [Related]
13. The microbial metabolite urolithin A reduces
Ghosh S; Erickson D; Chua MJ; Collins J; Jala VR
mSystems; 2024 Feb; 9(2):e0125523. PubMed ID: 38193707
[No Abstract] [Full Text] [Related]
14. Clostridium difficile toxins A and B decrease intestinal SLC26A3 protein expression.
Coffing H; Priyamvada S; Anbazhagan AN; Salibay C; Engevik M; Versalovic J; Yacyshyn MB; Yacyshyn B; Tyagi S; Saksena S; Gill RK; Alrefai WA; Dudeja PK
Am J Physiol Gastrointest Liver Physiol; 2018 Jul; 315(1):G43-G52. PubMed ID: 29597352
[TBL] [Abstract][Full Text] [Related]
15. Clostridium difficile Toxin B causes epithelial cell necrosis through an autoprocessing-independent mechanism.
Chumbler NM; Farrow MA; Lapierre LA; Franklin JL; Haslam DB; Goldenring JR; Lacy DB
PLoS Pathog; 2012; 8(12):e1003072. PubMed ID: 23236283
[TBL] [Abstract][Full Text] [Related]
16. Human peptide α-defensin-1 interferes with Clostridioides difficile toxins TcdA, TcdB, and CDT.
Fischer S; Ückert AK; Landenberger M; Papatheodorou P; Hoffmann-Richter C; Mittler AK; Ziener U; Hägele M; Schwan C; Müller M; Kleger A; Benz R; Popoff MR; Aktories K; Barth H
FASEB J; 2020 May; 34(5):6244-6261. PubMed ID: 32190927
[TBL] [Abstract][Full Text] [Related]
17. High temporal resolution of glucosyltransferase dependent and independent effects of Clostridium difficile toxins across multiple cell types.
D'Auria KM; Bloom MJ; Reyes Y; Gray MC; van Opstal EJ; Papin JA; Hewlett EL
BMC Microbiol; 2015 Feb; 15(1):7. PubMed ID: 25648517
[TBL] [Abstract][Full Text] [Related]
18. Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation.
Garg A; Zhao A; Erickson SL; Mukherjee S; Lau AJ; Alston L; Chang TK; Mani S; Hirota SA
J Pharmacol Exp Ther; 2016 Oct; 359(1):91-101. PubMed ID: 27440420
[TBL] [Abstract][Full Text] [Related]
19. Glucosyltransferase-dependent and independent effects of Clostridioides difficile toxins during infection.
Peritore-Galve FC; Shupe JA; Cave RJ; Childress KO; Washington MK; Kuehne SA; Lacy DB
PLoS Pathog; 2022 Feb; 18(2):e1010323. PubMed ID: 35176123
[TBL] [Abstract][Full Text] [Related]
20. Selection and characterization of ultrahigh potency designed ankyrin repeat protein inhibitors of C. difficile toxin B.
Simeon R; Jiang M; Chamoun-Emanuelli AM; Yu H; Zhang Y; Meng R; Peng Z; Jakana J; Zhang J; Feng H; Chen Z
PLoS Biol; 2019 Jun; 17(6):e3000311. PubMed ID: 31233493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]